Calvin Sandra's Form 4 filing
Travere Therapeutics, Inc. (TVTX) · filed Sep 17, 2026
- Accession no.
- 0001882909-26-000004
- Filed
- Sep 17, 2026, 9:29 PM ET
- Trade date
- Sep 15, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $335.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Calvin SandraCIK 0001882909 | Officer (SVP, CHIEF ACCOUNTING OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | MOption exerciseAcquired | +2,500 | $27.50 | +$68,750 | 44,853 | Direct | |
| Sep 15, 2026 | Common Stock | MOption exerciseAcquired | +1,250 | $22.40 | +$28,000 | 46,103 | Direct | |
| Sep 15, 2026 | Common Stock | MOption exerciseAcquired | +1,625 | $20.46 | +$33,247.5 | 47,728 | Direct | |
| Sep 15, 2026 | Common Stock | SSaleDisposed | −4,275 | $62.14 | −$265,627.13 | 43,453 | Direct | |
| Sep 15, 2026 | Common Stock | SSaleDisposed | −800 | $62.85 | −$50,278.48 | 42,653 | Direct | |
| Sep 15, 2026 | Common Stock | SSaleDisposed | −300 | $63.66 | −$19,098.99 | 42,353 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | MOption exerciseDisposed | −2,500 | $0.00 | $0 | 0 | Direct | |
| Sep 15, 2026 | Common Stock | MOption exerciseDisposed | −1,250 | $0.00 | $0 | 3,750 | Direct | |
| Sep 15, 2026 | Common Stock | MOption exerciseDisposed | −1,625 | $0.00 | $0 | 17,875 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.